Influenza, SARS-CoV-2, Titin, and Sudden Unexpected Deaths: On the Risk of Multiple Vaccinations

Authors

  • Darja Kanduc Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, Bari-70126, Italy.

DOI:

https://doi.org/10.9734/bpi/cimms/v10/7808F

Keywords:

Influenza, SARS-CoV-2, vaccinations, titin, sudden unexpected death, molecular mimicry, peptide sharing, cross-reactivity, autoimmunity

Abstract

Objective of this short review is to recall data that connect Influenza virus, severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), and the human cardiac Titin protein to sudden unexpected deaths (SUDs) through molecular mimicry. Indeed, a direct causality between Influenza virus and SUDs has been repeatedly reported in clinical literature and, more recently, also SARS-CoV-2 vaccination has been related to an alarming incidence of SUDs. Hence, it is of relevance to highlight that Influenza virus and SARS-CoV-2 antigens, i.e., hemagglutinin and spike glycoprotein (gp), share immune determinants with the SUD-related Titin. Such a peptide sharing and the consequent autoimmune cross-reactivity are even more significant since might enable an exponential implementation of SUD events following simultaneous multiple anti-influenza and anti-SARS-CoV-2 vaccinations. On the whole, this possibility imposes caution and careful vaccination clinical trials.

Published

2022-12-10

How to Cite

Darja Kanduc. (2022). Influenza, SARS-CoV-2, Titin, and Sudden Unexpected Deaths: On the Risk of Multiple Vaccinations. Current Innovations in Medicine and Medical Science Vol. 10, 1–10. https://doi.org/10.9734/bpi/cimms/v10/7808F